Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
This article compares retirement index funds and target date funds to help you decide which aligns with your goals and timeline.
26,044 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
When a payments giant tops the headline numbers, savvy investors look beyond the beat. This article breaks down why v...
Uniswap activated its fee switch today, enabling on-chain UNI buybacks funded by protocol fees. The move links revenu...
As AI reshapes markets, Palantir’s unique software moat could ignite a new chapter in growth. This guide compares Pal...
New fiscal data show that the cost of servicing the national debt is on track to exceed Medicare spending this year, ...
Oil volatility tied to Middle East tensions is raising fuel costs and could push grocery prices higher. Here’s what s...
A growing claim about Chrome downloads a 4GB AI model and quietly reinstalls it if deleted. This article explains wha...
DHL Supply Chain’s push to automation has rolled out 8,000 robots changing work across its global network, delivering...
Can a meme-inspired token under $1 truly be a smart long-term buy? This guide breaks down the economics, risks, and r...
As power demand climbs, nuclear energy offers reliable baseload power and steady dividends. Here are three nuclear st...
A new Goldman Sachs note argues that AI’s next growth wave hinges on optical networking, not just faster GPUs. Lument...
Bitcoin surged toward $71k and then cooled near $70k as geopolitical headlines about Iran dominated market sentiment,...